Lynparza use extended in EMA CHMP meeting
The positive opinion is based on data from the pivotal Phase III SOLO-1 trial.
Read More
Tag: extension
MSD’s Keytruda granted FDA extension
The approval is based on results from the Phase III KEYNOTE-042 trial.
Read More
New Brexit date is a ‘relief’, says NHS Confederation
The UK has been granted a six-month Brexit extension to October 31.
Read More
Lynparza, Dupixent backed by CHMP for label extensions
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended extending the uses of AstraZeneca’s Lynparza and Sanofi’s Dupixent.
Read More
GSK extends expiration date for Tesaro offer
GlaxoSmithKline subsidiary Adriatic Acquisition Corporation (AAC) has extended the expiration date for its tender offer for US-based Tesaro.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
